E

Edesa Biotech

D
EDSA
USD
-0.17
(-7.173%)
Market Closed
61.000
Volume
-2.225
EPS
-
Div Yield
-0.111223
P/E
7,144,255.80
Market Cap
Today
-7.1730%
1 Week
-19.708%
1 Month
-45.409%
6 Months
-53.684%
12 Months
-13.725%
Year To Date
-51.754%
All Time
0%

Title:
Edesa Biotech

Sector:
Healthcare
Industry:
Biotechnology
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Do you need help or have a question?